$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011519 Filed on March 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.871M	$7.013M	$30.26M
YoY Change	-67.54%	-38.37%	-36.04%
Cost Of Revenue	$4.990M	$7.210M	$26.65M
YoY Change	-41.52%	-26.5%	-28.87%
Gross Profit	-$1.119M	-$197.0K	$3.611M
YoY Change	-132.98%	-112.55%	-63.32%
Gross Profit Margin	-28.91%	-2.81%	11.93%
Selling, General & Admin	$3.561M	$2.314M	$25.07M
YoY Change	-60.31%	-79.05%	-53.16%
% of Gross Profit			694.32%
Research & Development	$50.00K	$463.0K	$1.147M
YoY Change	-72.07%	-15.97%	-8.68%
% of Gross Profit			31.76%
Depreciation & Amortization	$582.0K	$1.056M	$5.206M
YoY Change	-56.34%	-70.45%	-59.72%
% of Gross Profit			144.17%
Operating Expenses	$8.551M	$4.036M	$51.72M
YoY Change	-51.15%	-69.46%	-43.16%
Operating Profit	-$4.680M	-$4.233M	-$21.46M
YoY Change	-16.13%	-63.65%	-50.88%
Interest Expense	$48.00K	-$2.544M	$553.0K
YoY Change	-80.72%	198.24%	-81.0%
% of Operating Profit
Other Income/Expense, Net	$21.00K	$1.535M	$532.0K
YoY Change	-132.31%	-355.41%	-85.23%
Pretax Income	-$5.084M	-$44.47M	-$97.50M
YoY Change	-41.11%	46.62%	40.31%
Income Tax	$25.00K	-$5.000K	$4.000K
% Of Pretax Income
Net Earnings	-$4.072M	-$30.30M	-$80.61M
YoY Change	-49.32%	12.54%	34.7%
Net Earnings / Revenue	-105.19%	-432.1%	-266.4%
Basic Earnings Per Share	-$0.58		-$11.52
Diluted Earnings Per Share	-$0.58	-$4.32	-$11.52
COMMON SHARES
Basic Shares Outstanding	7.067M shares	140.3M shares	6.996M shares
Diluted Shares Outstanding	7.067M shares		6.996M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.252M	$16.62M	$6.615M
YoY Change	-32.62%	-64.34%	-65.71%
Cash & Equivalents	$9.252M	$6.615M
Short-Term Investments		$10.00M
Other Short-Term Assets	$52.36M	$52.43M	$52.43M
YoY Change	2462.9%	2984.35%	2984.35%
Inventory	$3.627M	$2.819M	$2.819M
Prepaid Expenses
Receivables	$2.863M	$3.994M	$3.994M
Other Receivables	$4.062M	$8.772M	$8.772M
Total Short-Term Assets	$72.16M	$74.63M	$74.63M
YoY Change	74.08%	55.51%	55.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.225M	$6.417M	$19.91M
YoY Change	-54.26%	-52.08%	-74.03%
Goodwill	$26.86M	$26.86M
YoY Change	-55.91%	-55.91%
Intangibles
YoY Change
Long-Term Investments	$127.0K	$128.0K	$11.39M
YoY Change	-19.11%	-20.99%	-60.73%
Other Assets	$133.0K	$97.00K	$97.00K
YoY Change	-95.17%	-96.41%	-96.41%
Total Long-Term Assets	$76.34M	$78.56M	$78.56M
YoY Change	-58.8%	-60.9%	-60.9%
TOTAL ASSETS
Total Short-Term Assets	$72.16M	$74.63M	$74.63M
Total Long-Term Assets	$76.34M	$78.56M	$78.56M
Total Assets	$148.5M	$153.2M	$153.2M
YoY Change	-34.51%	-38.46%	-38.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.084M	$3.654M	$3.654M
YoY Change	-19.84%	-38.21%	-38.21%
Accrued Expenses	$3.688M	$3.198M	$2.976M
YoY Change	-64.06%	-84.12%	-84.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$47.51M	$47.78M	$47.78M
YoY Change	-2.59%	1.3%	1.3%
Total Short-Term Liabilities	$56.21M	$55.61M	$55.61M
YoY Change	-12.99%	-24.53%	-24.53%
LONG-TERM LIABILITIES
Long-Term Debt	$7.431M	$7.451M	$7.451M
YoY Change	28.61%	-26.81%	-26.81%
Other Long-Term Liabilities	$6.752M		$6.917M
YoY Change	1231.76%		-16.93%
Total Long-Term Liabilities	$7.431M	$7.451M	$14.37M
YoY Change	18.23%	-30.29%	-22.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.21M	$55.61M	$55.61M
Total Long-Term Liabilities	$7.431M	$7.451M	$14.37M
Total Liabilities	$63.64M	$63.06M	$89.27M
YoY Change	-10.22%	-25.26%	-27.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$260.2M	-$256.2M
YoY Change	28.6%	31.82%
Common Stock	$140.0K	$140.0K
YoY Change	-94.96%	-94.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$59.86M	$63.93M	$63.93M
YoY Change
Total Liabilities & Shareholders Equity	$148.5M	$153.2M	$153.2M
YoY Change	-34.51%	-38.46%	-38.46%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.072M	-$30.30M	-$80.61M
YoY Change	-49.32%	12.54%	34.7%
Depreciation, Depletion And Amortization	$582.0K	$1.056M	$5.206M
YoY Change	-56.34%	-70.45%	-59.72%
Cash From Operating Activities	-$2.150M	$1.846M	-$19.19M
YoY Change	-84.86%	-149.86%	-28.79%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$138.0K	$818.0K
YoY Change	-99.49%	-89.16%	-64.34%
Acquisitions
YoY Change
Other Investing Activities	$5.100M	-$2.806M	$9.754M
YoY Change	-57.96%	-350.54%	-164.31%
Cash From Investing Activities	$5.097M	-$2.954M	$8.936M
YoY Change	-55.82%	1830.72%	-149.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$1.062M		$4.246M
YoY Change	-73.46%		21.18%
Cash From Financing Activities	-$310.0K	823.0K	-$2.417M
YoY Change	-89.3%	174.33%	-131.73%
NET CHANGE
Cash From Operating Activities	-$2.150M	1.846M	-$19.19M
Cash From Investing Activities	$5.097M	-2.954M	$8.936M
Cash From Financing Activities	-$310.0K	823.0K	-$2.417M
Net Change In Cash	$2.637M	-285.0K	-$12.68M
YoY Change	-147.45%	-91.98%	-66.02%
FREE CASH FLOW
Cash From Operating Activities	-$2.150M	$1.846M	-$19.19M
Capital Expenditures	$3.000K	$138.0K	$818.0K
Free Cash Flow	-$2.153M	$1.708M	-$20.01M
YoY Change	-85.45%	-134.33%	-31.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	DSS	Impairment Of Investment ImpairmentOfInvestment		usd
CY2023	DSS	Impairment Of Fixed Assets ImpairmentOfFixedAssets		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	DSS	Impairment Of Goodwill ImpairmentOfGoodwill		usd
CY2022	DSS	Provision For Loan Losses ProvisionForLoanLosses		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023	DSS	Impairment Of Property Plant And Equipment ImpairmentOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	DSS	Impairment Of Accounts Receivable ImpairmentOfAccountsReceivable		usd
CY2023	DSS	Impairment Of Other Investments ImpairmentOfOtherInvestments		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates		usd
CY2023	DSS	Payments For Proceeds From Investments Excluding Notes Receivables PaymentsForProceedsFromInvestmentsExcludingNotesReceivables		usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	DSS	Payments To Acquire Businesses Net Of Cash Acquired One PaymentsToAcquireBusinessesNetOfCashAcquiredOne		usd
CY2023	DSS	Conversion Of Shrg To Consolidation ConversionOfShrgToConsolidation		usd
CY2023	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	DSS	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2021Q4	DSS	Loan Loss Reserve LoanLossReserve		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	DSS	Loan Loss Reserve Bad Debt Expense LoanLossReserveBadDebtExpense		usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2022	DSS	Loan Loss Reserve Write Offs LoanLossReserveWriteOffs		usd
CY2022	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Write Offs AllowanceForDoubtfulAccountsAndLoanLossReserveWriteOffs		usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		usd
CY2022	DSS	Loan Loss Reserve Recoveries LoanLossReserveRecoveries		usd
CY2022	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Recoveries AllowanceForDoubtfulAccountsAndLoanLossReserveRecoveries		usd
CY2023	DSS	Loan Loss Reserve Write Offs LoanLossReserveWriteOffs		usd
CY2023	DSS	Loan Loss Reserve Recoveries LoanLossReserveRecoveries		usd
CY2023Q4	us-gaap	Deferred Income DeferredIncome		usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2023	DSS	Deferred Income Tax Net Of Discontinued Operations DeferredIncomeTaxNetOfDiscontinuedOperations		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential		pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023	DSS	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets		usd
CY2023	DSS	Notes Receivable Conversion To Equity NotesReceivableConversionToEquity		usd
CY2023	DSS	Right Of Use Asset Addition RightOfUseAssetAddition		usd
CY2022	DSS	Third Party Note Receivable Received In Lieu Of Cash ThirdPartyNoteReceivableReceivedInLieuOfCash		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.02 per share
CY2023	dei	Trading Symbol TradingSymbol	DSS
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	20278452	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7066772	shares
CY2023	dei	Auditor Firm AuditorFirmId	606
CY2023	dei	Auditor Name AuditorName	GRASSI & CO., CPAs, P.C.
CY2023	dei	Auditor Location AuditorLocation	Jericho, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6615000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19290000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3994000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2819000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	8772000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11719000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	51595000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	839000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	74634000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47994000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6417000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6279000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	1282000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1534000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	128000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	162000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	9979000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27307000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	111000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	922000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	97000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2699000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7210000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8219000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26862000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	60919000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	20193000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30740000	usd
CY2023Q4	us-gaap	Assets Assets	153192000	usd
CY2022Q4	us-gaap	Assets Assets	248916000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3654000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5914000	usd
CY2023Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	2512000	usd
CY2022Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	19341000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	983000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	447000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	686000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47776000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47161000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	55611000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73689000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7451000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10181000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6917000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7066772	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7066772	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6950858	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6950858	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	140000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	139000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319963000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319766000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256176000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194343000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	63927000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125562000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	19286000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	31119000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83213000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153192000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	248916000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47307000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25072000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	51719000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	93778000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-21461000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-46471000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1289000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	629000	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	16000	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	159000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	532000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3602000	usd
CY2023	us-gaap	Interest Expense InterestExpense	553000	usd
CY2022	us-gaap	Interest Expense InterestExpense	126000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	8750000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	129000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-32986000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10697000	usd
CY2022	DSS	Impairment Of Investment ImpairmentOfInvestment	5637000	usd
CY2022	DSS	Impairment Of Fixed Assets ImpairmentOfFixedAssets	2843000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7418000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	812000	usd
CY2023	DSS	Impairment Of Goodwill ImpairmentOfGoodwill	30978000	usd
CY2023	DSS	Provision For Loan Losses ProvisionForLoanLosses	-3794000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1300000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-97499000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69490000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-97503000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-69662000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-16897000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9822000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-80606000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59840000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.52
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.72
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.52
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.72
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6996322	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5581106	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6996322	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5581106	shares
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-97503000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-69662000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5206000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12925000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
CY2023	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-34000	usd
CY2022	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	129000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-33506000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-13386000	usd
CY2023	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	-1009000	usd
CY2022	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	7721000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	38000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1300000	usd
CY2022	DSS	Impairment Of Property Plant And Equipment ImpairmentOfPropertyPlantAndEquipment	2843000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7418000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	812000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	30978000	usd
CY2023	DSS	Impairment Of Accounts Receivable ImpairmentOfAccountsReceivable	3023000	usd
CY2023	DSS	Impairment Of Notes Receivable ImpairmentOfNotesReceivable	3794000	usd
CY2022	DSS	Impairment Of Notes Receivable ImpairmentOfNotesReceivable	1525000	usd
CY2022	DSS	Impairment Of Other Investments ImpairmentOfOtherInvestments	5637000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1316000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1891000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5483000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-540000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-996000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1766000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2392000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2210000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2260000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3994000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15646000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4307000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1013000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-39000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-298000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19194000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26953000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	818000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2294000	usd
CY2022	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates	732000	usd
CY2022	DSS	Payments For Proceeds From Investments Excluding Notes Receivables PaymentsForProceedsFromInvestmentsExcludingNotesReceivables	195000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14884000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	248000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2152000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1879000	usd
CY2023	DSS	Payments To Acquire Businesses Net Of Cash Acquired One PaymentsToAcquireBusinessesNetOfCashAcquiredOne	-40000	usd
CY2022	DSS	Conversion Of Shrg To Consolidation ConversionOfShrgToConsolidation	3038000	usd
CY2022	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment	113000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1046000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	3621000	usd
CY2023	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1010000	usd
CY2022	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1067000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9502000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	508000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8936000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17969000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4246000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3504000	usd
CY2023	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	1829000	usd
CY2022	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	9602000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1519000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2417000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7617000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	-12675000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	-37305000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6615000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17405000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1274000	usd
CY2022	DSS	Adjustments To Additional Paid In Capital Acquisition Of Sharing Services Global Corporation AdjustmentsToAdditionalPaidInCapitalAcquisitionOfSharingServicesGlobalCorporation	3257000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6221000	usd
CY2022	DSS	Net Loss NetLoss	-69661000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	268000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	70000	usd
CY2023	DSS	Deconsolidation Of Sharing Services Global Corporation DeconsolidationOfSharingServicesGlobalCorporation	23837000	usd
CY2023	DSS	Net Loss NetLoss	-97503000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83213000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83213000	usd
CY2023Q2	DSS	Deconsolidation On Loss Before Income Taxes DeconsolidationOnLossBeforeIncomeTaxes	29196000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zTwVWj9ujrwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z3AHKwN59B29">Use of Estimates</span> </i></b></span>– The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue, and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z93dN6r06RVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zSWh50nA8Kh9">Reclassifications</span> </i></b></span>– Interest expense associated with the debt owed by AMRE has been reclassed from Interest expense to Cost of revenue for the year ended December 31, 2022 to conform to current period presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2494000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5673000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3994000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zl35uTkSCKve" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zW0OfasrYaZk">Concentration of Credit Risk</span></i></b> - The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk because of any non-performance by the financial institutions. As of December 31, 2022, two customers accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zH91dUDikOUk">14%</span> and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z64yYcqKBMc2">6%</span> of our consolidated revenue and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRcgs2vK8unc">36%</span> and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztOcBfE6A6Ve">17%</span> of our trade accounts receivable balance. As of December 31, 2023, two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUHTmNovVDul" title="Concentration risk, percentage">20%</span> and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfUXPZoFiPHc" title="Concentration risk, percentage">11%</span> of our consolidated revenue and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPirraihki47" title="Concentration risk, percentage">39%</span> and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrX90TAM9u3b" title="Concentration risk, percentage">30%</span> of our trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q4	us-gaap	Other Assets OtherAssets	65000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7418000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1147000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1256000	usd
CY2023Q4	DSS	Sales Commissions Capitalized SalesCommissionsCapitalized	0	usd
CY2023Q4	us-gaap	Cash Cash	6600000	usd
CY2023Q4	us-gaap	Cash Cash	6600000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	10000000.0	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	8800000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	51600000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2218000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6779000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	180000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	403000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	439000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1281000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	2837000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	8463000	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	18000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2819000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	20000	usd
CY2021Q4	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve AllowanceForDoubtfulAccountsAndLoanLossReserve	20000	usd
CY2022	DSS	Loan Loss Reserve Credit Loss Expense LoanLossReserveCreditLossExpense	1041000	usd
CY2022	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Credit Loss Expense AllowanceForDoubtfulAccountsAndLoanLossReserveCreditLossExpense	1041000	usd
CY2022	DSS	Allowance For Doubtful Accounts Receivable Bad Debt Expense AllowanceForDoubtfulAccountsReceivableBadDebtExpense	9000	usd
CY2022	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Bad Debt Expense AllowanceForDoubtfulAccountsAndLoanLossReserveBadDebtExpense	9000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29000	usd
CY2022Q4	DSS	Loan Loss Reserve LoanLossReserve	1041000	usd
CY2022Q4	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve AllowanceForDoubtfulAccountsAndLoanLossReserve	1070000	usd
CY2023	DSS	Allowance For Doubtful Accounts Receivable Bad Debt Expense AllowanceForDoubtfulAccountsReceivableBadDebtExpense	2000	usd
CY2023	DSS	Loan Loss Reserve Bad Debt Expense LoanLossReserveBadDebtExpense	5069000	usd
CY2023	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Bad Debt Expense AllowanceForDoubtfulAccountsAndLoanLossReserveBadDebtExpense	5071000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3500000	usd
CY2023	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Write Offs AllowanceForDoubtfulAccountsAndLoanLossReserveWriteOffs	3500000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1037000	usd
CY2023	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve Recoveries AllowanceForDoubtfulAccountsAndLoanLossReserveRecoveries	1037000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2494000	usd
CY2023Q4	DSS	Loan Loss Reserve LoanLossReserve	6110000	usd
CY2023Q4	DSS	Allowance For Doubtful Accounts And Loan Loss Reserve AllowanceForDoubtfulAccountsAndLoanLossReserve	8604000	usd
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	33919000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-17325000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16594000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6615000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9979000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	68914000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-17976000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	50938000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19290000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27307000	usd
CY2022Q4	us-gaap	Investments Investments	4341000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5521000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2757000	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-1973000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	1077000	usd
CY2023	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-3548000	usd
CY2022	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-3834000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11338000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17578000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4921000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4187000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6417000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2023	us-gaap	Depreciation Depreciation	802000	usd
CY2022	us-gaap	Depreciation Depreciation	1569000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	6873000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	57526000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	594000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	2497000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6279000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2023Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	2085000	usd
CY2022Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	2077000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43057000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15446000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7418000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20193000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43835000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13095000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30740000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2319000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3012000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3009000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2860000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5574000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	222000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	188000	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	519000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	812000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4014000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	8974000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	926000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1468000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4536000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	172000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	10000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	12000	usd
CY2023Q4	DSS	Accrued Expense And Deferred Revenue Current AccruedExpenseAndDeferredRevenueCurrent	2512000	usd
CY2022Q4	DSS	Accrued Expense And Deferred Revenue Current AccruedExpenseAndDeferredRevenueCurrent	19341000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	47776000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	859000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	901000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	947000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3544000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	55227000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	956000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	861000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	839000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	808000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	824000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4913000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9201000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1598000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7603000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	686000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6917000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	790000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	975000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2024Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 20
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	140264240	shares
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	139017000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7066772	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7066772	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6950858	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6950858	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	5333	shares
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	119000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	134000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5392000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14839000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-79000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-492000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-48000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-58000	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-5519000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15390000	usd
CY2023	DSS	Deferred Income Tax Expense Benefit Increase Derease In Allowance DeferredIncomeTaxExpenseBenefitIncreaseDereaseInAllowance	-5519000	usd
CY2022	DSS	Deferred Income Tax Expense Benefit Increase Derease In Allowance DeferredIncomeTaxExpenseBenefitIncreaseDereaseInAllowance	-15427000	usd
CY2022	DSS	Deferred Income Tax Net Of Discontinued Operations DeferredIncomeTaxNetOfDiscontinuedOperations	38000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21496000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24975000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	9634000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	9634000	usd
CY2023Q4	DSS	Deferred Tax Assets Unrealized Loss On Securities DeferredTaxAssetsUnrealizedLossOnSecurities	4655000	usd
CY2022Q4	DSS	Deferred Tax Assets Unrealized Loss On Securities DeferredTaxAssetsUnrealizedLossOnSecurities	5753000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	190000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	190000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	63000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	34000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	11000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	11000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	176000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	176000	usd
CY2023Q4	DSS	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	1713000	usd
CY2022Q4	DSS	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	1935000	usd
CY2023Q4	DSS	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	1000	usd
CY2022Q4	DSS	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	24000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2507000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	696000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40446000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33794000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	3369000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2822000	usd
CY2023Q4	DSS	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	614000	usd
CY2022Q4	DSS	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	-194000	usd
CY2023Q4	DSS	Deferred Tax Liabilities Rightof Use Asset DeferredTaxLiabilitiesRightofUseAsset	1625000	usd
CY2022Q4	DSS	Deferred Tax Liabilities Rightof Use Asset DeferredTaxLiabilitiesRightofUseAsset	1846000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5608000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4474000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34838000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29357000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	38000	usd
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	43800000	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2900000	usd
CY2023	DSS	Net Operating Loss Carryforwards Expiration Date Descrption NetOperatingLossCarryforwardsExpirationDateDescrption	expire through 2043
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5500000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15400000	usd
CY2023	DSS	Increase Decrease In Deferred Tax Liabilities Valuation Allowance IncreaseDecreaseInDeferredTaxLiabilitiesValuationAllowance	1100000	usd
CY2022	DSS	Increase Decrease In Deferred Tax Liabilities Valuation Allowance IncreaseDecreaseInDeferredTaxLiabilitiesValuationAllowance	9900000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0038	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0051	pure
CY2023	DSS	Effective Income Tax Rate Reconciliation Permanent Difference EffectiveIncomeTaxRateReconciliationPermanentDifference	-0.0668	pure
CY2022	DSS	Effective Income Tax Rate Reconciliation Permanent Difference EffectiveIncomeTaxRateReconciliationPermanentDifference	0.0003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0904	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0093	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0007	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0566	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2266	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0025	pure
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2018Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	124000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	124000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	4812000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3270000	usd
CY2022	DSS	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	9568000	usd
CY2023	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash	268000	usd
CY2022	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash	6221000	usd
CY2022	DSS	Notes Receivable Conversion To Equity NotesReceivableConversionToEquity	8717000	usd
CY2022	DSS	Right Of Use Asset Addition RightOfUseAssetAddition	7169000	usd
CY2023	DSS	Third Party Note Receivable Received In Lieu Of Cash ThirdPartyNoteReceivableReceivedInLieuOfCash	1100000	usd

Files In Submission

Name	View Source	Status
0001493152-24-011519-index-headers.html	Edgar Link	pending
0001493152-24-011519-index.html	Edgar Link	pending
0001493152-24-011519.txt	Edgar Link	pending
0001493152-24-011519-xbrl.zip	Edgar Link	pending
dss-20231231.xsd	Edgar Link	pending
ex10-18.htm	Edgar Link	pending
ex10-53.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
dss-20231231_cal.xml	Edgar Link	unprocessable
dss-20231231_def.xml	Edgar Link	unprocessable
dss-20231231_lab.xml	Edgar Link	unprocessable
dss-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2024 Q1 Form 10-K Financial Statement

#000149315224011519 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2024 Q1 Form 10-K Financial Statement

#000149315224011519 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss